Simply Solventless Concentrates Ltd. Share Price
Stocks
HASH
CA82888A1021
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0500 CAD | -.--% |
|
-9.09% | -64.29% |
| 06-19 | Simply Solventless Expects to File Financial Statements by July 3 | MT |
| 04-30 | Simply Solventless Concentrates Ltd. Appoints William Macdonald as Interim Chief Financial Officer | CI |
| Market Cap | 16.17M 11.39M 10M 9.2M 8.57M 1.08B 16.5M 111M 42.88M 531M 42.75M 41.83M 1.85B | P/E 2023 |
7.5x | P/E 2024 | -10x |
|---|---|---|---|---|---|
| Enterprise Value | 25.27M 17.79M 15.62M 14.38M 13.4M 1.69B 25.78M 173M 67.01M 830M 66.81M 65.36M 2.89B | EV / Sales 2023 |
1.44x | EV / Sales 2024 | 6.8x |
| Free-Float |
81.55% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 week | -9.09% | ||
| 1 month | +25.00% | ||
| 3 months | -9.09% | ||
| 6 months | -64.29% | ||
| Current year | -64.29% |
| 1 week | 0.05 |  | 0.06 |
| 1 month | 0.04 | | 0.06 |
| Current year | 0.04 | | 0.19 |
| 1 year | 0.04 | | 0.4 |
| 3 years | 0.04 | | 0.84 |
| 5 years | 0.04 | | 0.84 |
| 10 years | 0.04 | | 0.84 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02-09 | Buy | Director | 9,500 | 0.0098% | ||
| 02-09 | Buy | Director | 5,500 | 0.0057% | ||
| 02-09 | Buy | Director | 5,000 | 0.0052% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -9.09% | -77.27% | -80.77% | 4.07M | |
| +1.27% | -1.15% | -14.02% | -8.59% | 12.44B | |
| +0.61% | -1.52% | -35.52% | -59.61% | 4.67B | |
| +1.50% | +1.63% | -11.97% | -13.86% | 4.29B | |
| +2.33% | -0.58% | +8.87% | -40.25% | 3.69B | |
| +2.98% | +1.48% | +14.90% | -14.61% | 3.68B | |
| +1.22% | -13.98% | -14.70% | -22.66% | 3.01B | |
| +2.80% | -1.95% | -13.10% | -6.27% | 2.91B | |
| +3.15% | -1.57% | -7.27% | -26.86% | 2.27B | |
| +3.04% | -0.25% | -11.91% | +24.35% | 1.61B | |
| Average | +1.89% | +0.44% | -16.20% | -24.91% | 3.86B | |
| Weighted average by Cap. | +1.78% | +0.97% | -10.95% | -19.59% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 6.19M 4.36M 3.83M 3.52M 3.28M 414M 6.32M 42.38M 16.42M 203M 16.37M 16.01M 708M | 13.68M 9.63M 8.46M 7.78M 7.25M 916M 13.96M 93.62M 36.27M 449M 36.16M 35.38M 1.56B |
| Net income | 1.04M 732K 643K 592K 552K 69.64M 1.06M 7.12M 2.76M 34.18M 2.75M 2.69M 119M | -5.19M -3.66M -3.21M -2.96M -2.75M -348M -5.3M -35.55M -13.77M -171M -13.73M -13.44M -594M |
| Net Debt | 1.63M 1.15M 1.01M 927K 864K 109M 1.66M 11.15M 4.32M 53.52M 4.31M 4.21M 186M | 9.1M 6.41M 5.63M 5.18M 4.83M 609M 9.28M 62.28M 24.13M 299M 24.06M 23.54M 1.04B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/06/26 | CA$0.0500 | -.--% | 38,000 |
| 29/06/26 | CA$0.0500 | -.--% | 72,000 |
| 26/06/26 | CA$0.0500 | -9.09% | 57,500 |
| 25/06/26 | CA$0.0550 | +10.00% | 138,042 |
| 24/06/26 | CA$0.0500 | -9.09% | 11,002 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- HASH Stock
Select your edition
All financial news and data tailored to specific country editions
